United States
As of 05/19/2025, Lotus Pharmaceuticals's market capitalization has reached $14.02 M. According to our data, Lotus Pharmaceuticals is the 37637th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 14.02 M |
| Revenue (ttm) | 71.39 M |
| Net Income (ttm) | 1.72 M |
| Shares Out | 2.64 B |
| EPS (ttm) | 0.06 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
| Date | Market Cap | Change (%) |
|---|---|---|
| 05/19/2025 | $14.02 M | -20% |
| 12/31/2024 | $15.87 M | 26.79% |
| 12/29/2023 | $12.51 M | -57.5% |
| 12/30/2022 | $29.45 M | -41% |
| 12/31/2021 | $49.91 M | 54.09% |
| 12/31/2020 | $32.39 M |
Current Status: Lotus Pharmaceuticals, Inc. does not have significant operations at this time.
The company was previously involved in:
Headquarters: Nashville, Tennessee
| Country or region | United States |
| Founded | 0 |
| IPO Date | n/a |
| Employees | 383 |
| CEO | Zhong Yi Liu |
| Sector | Financials |
| Industry | Shell Companies |
| Address |
813 Blue Ridge Drive Nashville, Nevada 37207 United States |
| Website | https://lotuspharmaceuticalsusa.com |
